FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
Stephen A. Harrison, Tim Rolph, Madeline Knott, Julie Dubourg
Topics & Concepts
SteatohepatitisTherapeutic windowMedicineFGF21Nonalcoholic steatohepatitisInternal medicineFatty liverPharmacologyDiseaseReceptorNonalcoholic fatty liver diseaseFibroblast growth factorFibroblast Growth Factor ResearchEpigenetics and DNA MethylationKruppel-like factors research